Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CTIC - CTI BioPharma Corp


Previous close
9.09
9.090   100.000%

Share volume: 0
Last Updated: Fri 23 Jun 2023 08:00:00 PM CEST
Pharmaceutical Preparation Manufacturing : 2.72%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023
Report Date 2022-05-12 2022-08-08 2022-11-07 2023-03-06 2023-05-15
Total revenue 2.295 M 12.329 M 18.241 M 21.083 M 24.116 M
Cost of revenue 278.000 K 917.000 K 1.152 M 1.167 M 1.224 M
Gross profit 2.017 M 11.412 M 17.089 M 19.916 M 22.892 M
    465.79% 49.75% 16.54% 14.94%  
Operating expenses 26.094 M 30.295 M 29.718 M 35.614 M 32.124 M
Selling general and admin 18.046 M 21.590 M 21.498 M 23.692 M 21.913 M
Research and development 8.048 M 8.705 M 8.220 M 11.922 M 10.211 M
Total expenses 37.395 M 31.212 M 30.459 M 34.679 M 33.348 M
    -16.53% -2.41% 13.85% -3.84%  
Operating income -35.100 M -18.883 M -12.218 M -13.596 M -9.232 M
Ebit -35.100 M -18.883 M -12.218 M -13.596 M -9.232 M
Pretax income -37.175 M -22.654 M -15.705 M -17.458 M -13.422 M
    -39.06% -30.67% 11.16% -23.12%  
Income tax 0.000 0.000 0.000 0.000 0.000
Net income basic -37.175 M -22.654 M -15.705 M -17.458 M -13.422 M
    39.06% 30.67% -11.16% 23.12%  
Net income -37.175 M -22.654 M -15.705 M -17.458 M -13.422 M
    39.06% 30.67% -11.16% 23.12%